Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BRTX will decline by -13.18% over the next 2 Weeks and hit $0.16 by Tuesday, June 2, 2026. In that time frame, BRTX's share price is expected to range between $0.14 and $0.18.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 2, 2026 | 0.14 | 0.16 | 0.18 |
| Jun 1, 2026 | 0.15 | 0.16 | 0.18 |
| May 29, 2026 | 0.15 | 0.17 | 0.18 |
| May 28, 2026 | 0.15 | 0.16 | 0.18 |
| May 27, 2026 | 0.15 | 0.17 | 0.19 |
| May 26, 2026 | 0.15 | 0.17 | 0.19 |
| May 25, 2026 | 0.16 | 0.17 | 0.19 |
| May 22, 2026 | 0.16 | 0.18 | 0.20 |
| May 21, 2026 | 0.16 | 0.18 | 0.20 |
| May 20, 2026 | 0.16 | 0.18 | 0.20 |
BRTX shares fell -7.52% in Wednesday, May 20, 2026's trading session, dropping from a previous close of $0.18 to move at $0.17. The stock demonstrated notable intraday movement (see BRTX's key stats for a full breakdown), fluctuating between $0.16 and $0.18, a +10.23% trading range. While recent weeks have seen some volatility, BRTX has managed to secure a -24.53% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 17.34M shares changing hands, 16.95M more than the previous session. This amounted to $2.94M in total market activity.
Will BRTX Continue Its Upward Trend?
According to analyst ratings and projections for BRTX, BioRestorative Therapies, Inc. shares are anticipated to increase by +4.97%, potentially reaching $0.18 per share by June 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for BRTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the BRTX stock forecast, now is a good time to buy BRTX stock because its current trading price is +6.52% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BRTX covering social and institutional perspectives.
BRTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BRTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 25.46% to 33.34%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 35.17%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 39.34%, signals a bearish bias in the long-term trend. Insights into BRTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioRestorative Therapies Short-Term Forecasts
BRTX Forecast For Next 5 Days
Our algorithm anticipates BioRestorative Therapies (BRTX) stock could hit $0.15 by May 27, 2026. This represents a -10.31% fall from today's price, following a -5.27% change over the past five days.
BRTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BioRestorative Therapies, Inc. (BRTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.16, which would mean a -5.77% decrease from the current price of $0.17. Projections for this period range from a high of $0.22 to a low of $0.11.
BRTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BioRestorative Therapies's price over the next three months point to a rise. BRTX stock is expected to peak at $0.79 on May 21, 2026 before potentially dipping to $0.01 on Aug 12, 2026. On average, BRTX is likely to trade around $0.35 in the coming 90 days.
BioRestorative Therapies Stock Forecast 2025
Based on our predictive models, BioRestorative Therapies (BRTX) is expected to trade between $0.00 and $0.79 throughout 2026. This would result in an average price of $0.18, potentially offering investors a +6.01% return from current levels.
BioRestorative Therapies, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.53 and $0.79, settling at an average of $0.65. This could translate to a +282.80% gain.
June 2026
Based on current market signals, BioRestorative Therapies, Inc. is projected to trend june 2026. We forecast a trading range from $0.32 to $0.67, with a likely average price of $0.55. Investors could expect a potential return of +223.91%.
July 2026
Our predictive algorithms indicate BioRestorative Therapies, Inc. stock may see a shift in July 2026. The expected range spans $0.03–$0.45, with an average target of $0.21. This represents a positive outlook and a possible gain of +23.67%.
August 2026
Analyzing established trends, BioRestorative Therapies, Inc. looks set to move in August 2026. Projections place the stock between $0.01 and $0.19, averaging around $0.11. This suggests a -35.22% loss from current levels.
September 2026
Market indicators suggest BioRestorative Therapies, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $0.20, with a midpoint forecast of $0.08. The stock might deliver a -52.89% loss.
October 2026
Forecasting for October 2026, models estimate that BioRestorative Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.20, averaging $0.09. This signals a cautious trajectory with potential returns around -47.00%.
November 2026
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $0.13, settling at an average of $0.05. This could translate to a -70.55% loss.
December 2026
Based on current market signals, BioRestorative Therapies, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $0.11, with a likely average price of $0.04. Investors could expect a potential return of -76.44%.
January 2027
Our predictive algorithms indicate BioRestorative Therapies, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$0.08, with an average target of $0.04. This represents a cautious outlook and a possible loss of -76.44%.
February 2027
Analyzing established trends, BioRestorative Therapies, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $0.03, averaging around $0.04. This suggests a -76.44% loss from current levels.
March 2027
Market indicators suggest BioRestorative Therapies, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $0.05, with a midpoint forecast of $0.01. The stock might deliver a -94.11% loss.
April 2027
Forecasting for April 2027, models estimate that BioRestorative Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.02, averaging $0.01. This signals a cautious trajectory with potential returns around -94.11%.
May 2027
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.02. This could translate to a -88.22% loss.
BRTX's history of dividends and stock splits also plays a role in long-term investor confidence.